Structural Modifications Introduced by NS2B Cofactor Binding to the NS3 Protease of the Kyasanur Forest Disease Virus
- PMID: 37446083
- PMCID: PMC10342073
- DOI: 10.3390/ijms241310907
Structural Modifications Introduced by NS2B Cofactor Binding to the NS3 Protease of the Kyasanur Forest Disease Virus
Abstract
Kyasanur Forest Disease virus (KFDV), a neglected human pathogenic virus, is a Flavivirus that causes severe hemorrhagic fever in humans. KFDV is transmitted to humans by the bite of the hard tick (Haemaphysalis spinigera), which acts as a reservoir of KFDV. The recent expansion of the endemic area of KFDV is of concern and requires the development of new preventive measures against KFDV. Currently, there is no antiviral therapy against KFDV, and the existing vaccine has limited efficacy. To develop a new antiviral therapy against KFDV, we focused on the nonstructural proteins NS2B and NS3 of KFDV, which are responsible for serine protease activity. Viral proteases have shown to be suitable therapeutic targets in the development of antiviral drugs against many diseases. However, success has been limited in flaviviruses, mainly because of the important features of the active site, which is flat and highly charged. In this context, the present study focuses on the dynamics of NS2B and NS3 to identify potential allosteric sites in the NS2B/NS3 protease of KDFV. To our knowledge, there are no reports on the dynamics of NS2B and NS3 in KFDV, and the crystal structure of the NS2B/NS3 protease of KFDV has not yet been solved. Overall, we created the structure of the NS2B/NS3 protease of KFDV using AlphaFold and performed molecular dynamics simulations with and without NS2B cofactor to investigate structural rearrangements due to cofactor binding and to identify alternative allosteric sites. The identified allosteric site is promising due to its geometric and physicochemical properties and druggability and can be used for new drug development. The applicability of the proposed allosteric binding sites was verified for the best-hit molecules from the virtual screening and MD simulations.
Keywords: AlphaFold; KFDV; MD; NS2B; NS3; PCA; allosteric binding site; clustering; conformational change.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Allosteric quinoxaline-based inhibitors of the flavivirus NS2B/NS3 protease.Bioorg Chem. 2023 Feb;131:106269. doi: 10.1016/j.bioorg.2022.106269. Epub 2022 Nov 19. Bioorg Chem. 2023. PMID: 36446201 Free PMC article.
-
Potential Role of Flavivirus NS2B-NS3 Proteases in Viral Pathogenesis and Anti-flavivirus Drug Discovery Employing Animal Cells and Models: A Review.Viruses. 2021 Dec 28;14(1):44. doi: 10.3390/v14010044. Viruses. 2021. PMID: 35062249 Free PMC article. Review.
-
Dynamic Interactions of Post Cleaved NS2B Cofactor and NS3 Protease Identified by Integrative Structural Approaches.Viruses. 2022 Jun 30;14(7):1440. doi: 10.3390/v14071440. Viruses. 2022. PMID: 35891424 Free PMC article.
-
Epidemiology, Pathogenesis, and Control of a Tick-Borne Disease- Kyasanur Forest Disease: Current Status and Future Directions.Front Cell Infect Microbiol. 2018 May 9;8:149. doi: 10.3389/fcimb.2018.00149. eCollection 2018. Front Cell Infect Microbiol. 2018. PMID: 29868505 Free PMC article. Review.
-
Characterisation of ten NS2B-NS3 proteases: Paving the way for pan-flavivirus drugs.Antiviral Res. 2024 Jun;226:105878. doi: 10.1016/j.antiviral.2024.105878. Epub 2024 Apr 4. Antiviral Res. 2024. PMID: 38582134
Cited by
-
Kyasanur Forest Disease: A Comprehensive Review.Cureus. 2024 Jul 23;16(7):e65228. doi: 10.7759/cureus.65228. eCollection 2024 Jul. Cureus. 2024. PMID: 39184677 Free PMC article. Review.
-
Computational Exploration of Potential Pharmacological Inhibitors Targeting the Envelope Protein of the Kyasanur Forest Disease Virus.Pharmaceuticals (Basel). 2024 Jul 3;17(7):884. doi: 10.3390/ph17070884. Pharmaceuticals (Basel). 2024. PMID: 39065734 Free PMC article.
-
The Construction of a Molecular Model for the Ternary Protein Complex of Intrinsic Coagulation Pathway Factors Provides Novel Insights for the Pathogenesis of Cross-Reactive Material Positive Coagulation Factor Mutations.Int J Mol Sci. 2025 May 28;26(11):5191. doi: 10.3390/ijms26115191. Int J Mol Sci. 2025. PMID: 40508000 Free PMC article.
-
Molecular Insights into Macromolecules Structure, Function, and Regulation.Int J Mol Sci. 2024 May 13;25(10):5296. doi: 10.3390/ijms25105296. Int J Mol Sci. 2024. PMID: 38791335 Free PMC article.
-
Exploration of effective pharmacological inhibitors for NS5 protein through computational approach: A strategy to combat the neglected Kyasanur forest disease virus.PLoS One. 2025 Jul 10;20(7):e0325613. doi: 10.1371/journal.pone.0325613. eCollection 2025. PLoS One. 2025. PMID: 40638564 Free PMC article.
References
-
- Work T.H., Trapido H. Summary of Preliminary Report of Investigations of the Virus Research Centre on an Epidemic Disease Affecting Forest Villagers and Wild Monkeys of Shimoga District, Mysore. Indian J. Med. Sci. 1957;11:341–342. - PubMed
-
- Bhatt P.N., Work T.H., Varma M.G., Trapido H., Murthy D.P., Rodrigues F.M. Kyasanur Forest Diseases. IV. Isolation of Kyasanur Forest Disease Virus from Infected Humans and Monkeys of Shimogadistrict, Mysore State. Indian J. Med. Sci. 1996;20:316–320. - PubMed
-
- Dhaka R., Verma R., Kumar R., Dhankar M., Bhalla K., Agrawal G. Kyasanur Forest Disease: A Rare Viral Hemorrhagic Disease in India. Int. J. Community Med. Public Health. 2018;5:3149–3151. doi: 10.18203/2394-6040.ijcmph20183042. - DOI
-
- Trapido H., Rajagopalan P.K., Work T.H., Varma M G Kyasanur Forest Disease VIII. Isolation of Kyasanur Forest Disease Virus from Naturally Infected Ticks of the Genus Haemaphysalis. Indian J. Med. Res. 1959;47:133–138. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
